Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

January 2005

Stryker Corp. (NYSE:SYK) Reports 4Q:04 and 2004 Financials BY JOHN CHOPACK, JANUARY 31, 2005

Stryker reported 4Q:04 revenues of $1.156 billion which was an increase of 15% on a reported basis over the 3Q:04. This was slightly below analyst expectations of $1.158 billion in revenues. Earnings for the 4Q:04 totaled $0.40 per diluted share... more

OrthoLogic Reports 2004 Results: Fired Up On All Burners BY JOHN MCCORMICK, JANUARY 31, 2005

On Thursday of last week, OrthoLogic Corp. (Nasdaq: OLGC) announced its Q4:04 results. The Company, which has effectively been a drug development company since the sale of its bone growth stim business, reported a net loss of $4.9 million or... more

ArthroCare (NASDAQ:ARTC) Announces 29% Increase in Revenue for 2004 and Provides Guidance for 2005 BY HUYEN NGUYEN, JANUARY 31, 2005

Last week, ArthroCare (NASDAQ:ARTC) announced 4Q:04 product revenues will reach $40.8 million, a 30% increase from last year's fourth quarter. The company expects total product revenues for the fiscal year 2004 to total approximately $147.8 million, up 29% from the... more

Johnson & Johnson (NYSE:JNJ) Reports 4Q:04 Results: We Examine DePuy's Charite BY JOHN CHOPACK, JANUARY 31, 2005

JNJ reported revenues of $12.8 billion for the 4Q:04 which was a 13% increase over the 4Q:03. DePuy, JNJ's orthopedic division, reported revenues of $952 million for the 4Q:04. This was a 19% increase as reported and a 15% increase... more

Direct-to-Consumer Advertising Takes Hold in Orthopedics | EDITORIAL | BY JOHN CHOPACK, JANUARY 24, 2005

Direct-to-consumer advertising has become the most powerful means of marketing pharmaceuticals over the last decade. For years we have seen these strange advertisements which typically only mention the name of a drug and the manufacturer, but withhold any information regarding... more

LifeCell (LIFC:NASDAQ) Reports Preliminary 4Q:04 Financials and Provides 2005 Outlook BY JOHN CHOPACK, JANUARY 24, 2005

LIFC reported that it anticipated 4Q:04 product revenues to total $16.0 million which is a 49% increase over the 4Q:03. The company is anticipating 2004 product revenues to total $59 million compared to the $39 million reported during 2003 (52%... more

Symmetry Expands Facilities BY JOHN MCCORMICK, JANUARY 24, 2005

Warsaw, Indiana is forging ahead. Orthopedic industry supplier Symmetry Medical (NYSE:SMA) announced this morning that it has completed an $8.5 million facilities expansion. The projects undertaken included augmenting two existing facilities and developing two new facilities as follows (according to... more

Osteotech (OSTE: NASDAQ) Takes Charge and Shares Drop 33% Last Week BY JOHN CHOPACK, JANUARY 10, 2005

OSTE announced on Thursday that it was taking a $5.8 million pre-tax charge to write down assets during the 4Q:04. The Company now expects a loss of $0.28 to $0.31 for the fiscal year 2004 compared to the previous forecast... more

Smith & Nephew (SNN:NYSE) Receives FDA Approval For Ceramic-Ceramic Hip and Introduces Imageless Computer-Assisted Surgical Navigation System. BY JOHN CHOPACK, JANUARY 10, 2005

SNN became the fourth orthopedic manufacturer to gain FDA approval of a ceramic-on-ceramic hip behind Stryker Corp., Wright Medical and Encore Medical. Ceramic-on-ceramic hips offer superior wear characteristics compared to traditional polyethylene and metal-on-metal hips providing the potential to last... more

Orthofix gets Long-Awaited PMA BY JOHN MCCORMICK, JANUARY 10, 2005

In late December, Orthofix (Nasdaq: OFIX) announced a significant milestone: it received an FDA approval to market its Cervical-Stim' bone growth stimulator as an FDA Class III device. That makes Orthofix the first and only company to provide an FDA-approved... more

Privacy Policy BY EDITOR, JANUARY 1, 2005

HealthpointCapital will not share your email address with any third party. A sample of our weekly email is here. Please direct any questions about this policy to radmin@healthpointcapital.com, or call (212) 935-7780.... more

Orthopedic News Index by Topic BY EDITOR, JANUARY 1, 2005

Click the links on the left for news and commentary broken down by topical area. more

Product Type News Index BY EDITOR, JANUARY 1, 2005

Click the links on the left for news and commentary broken down by device type. more

Company News Index BY EDITOR, JANUARY 1, 2005

Click the links on the left for news and commentary on top device manufacturers. more


Complete Archive